Insider · CIK 0001496687

Machiels Alec

CIK 0001496687 Name as filed on the most recent filing

Filed as Machiels Alec (43)

44 transaction lines · from 43 filings · filed 2020-01-17 to 2023-11-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

44 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-11-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 59,675, disposed Open Form 4 filing 0001127602-23-027990
2023-10-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 60,625, disposed Open Form 4 filing 0001127602-23-026081
2023-09-18 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 56,250, disposed Open Form 4 filing 0001127602-23-024448
2023-09-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 56,675, disposed Open Form 4 filing 0001127602-23-024309
2023-07-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 80,988, disposed Open Form 4 filing 0001127602-23-020951
2023-06-20 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 110,513, disposed Open Form 4 filing 0001127602-23-019158
2023-05-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 110,825, disposed Open Form 4 filing 0001127602-23-016195
2023-04-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 101,313, disposed Open Form 4 filing 0001127602-23-013129
2023-03-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 80,038, disposed Open Form 4 filing 0001127602-23-010957
2023-02-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 65,475, disposed Open Form 4 filing 0001127602-23-006189
2023-01-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 65,525, disposed Open Form 4 filing 0001127602-23-001805
2022-12-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 65,438, disposed Open Form 4 filing 0001127602-22-027856
2022-11-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 60,013, disposed Open Form 4 filing 0000899243-22-036194
2022-10-14 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 74,138, disposed Open Form 4 filing 0001127602-22-023984
2022-09-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 82,500, disposed Open Form 4 filing 0001127602-22-022540
2022-08-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 84,013, disposed Open Form 4 filing 0001127602-22-021109
2022-07-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 57,913, disposed Open Form 4 filing 0001127602-22-019423
2022-06-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 49,113, disposed Open Form 4 filing 0001127602-22-017795
2022-05-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 48,975, disposed Open Form 4 filing 0001127602-22-014789
2022-04-14 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 63,625, disposed Open Form 4 filing 0001127602-22-012095
2022-03-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 49,463, disposed Open Form 4 filing 0000899243-22-011518
2022-02-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 56,788, disposed Open Form 4 filing 0001127602-22-005298
2022-01-14 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 50,700, disposed Open Form 4 filing 0000899243-22-002522
2021-12-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 128,640, disposed Open Form 4 filing 0001127602-21-031427
2021-11-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 130,500, disposed Open Form 4 filing 0001127602-21-029466
2021-11-04 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 105,000, disposed Open Form 4 filing 0001127602-21-029466
2021-08-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 142,375, disposed Open Form 4 filing 0001127602-21-023884
2021-07-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 155,750, disposed Open Form 4 filing 0001127602-21-022139
2021-06-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 162,075, disposed Open Form 4 filing 0001127602-21-020054
2021-05-14 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 113,475, disposed Open Form 4 filing 0001127602-21-017172
2021-04-21 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 114,400, disposed Open Form 4 filing 0001127602-21-014320
2021-03-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 116,925, disposed Open Form 4 filing 0001127602-21-011030
2021-02-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 115,000, disposed Open Form 4 filing 0001127602-21-006148
2021-01-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 132,875, disposed Open Form 4 filing 0001127602-21-001948
2020-12-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 130,400, disposed Open Form 4 filing 0001127602-20-031563
2020-11-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 98,450, disposed Open Form 4 filing 0001127602-20-029368
2020-10-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 87,500, disposed Open Form 4 filing 0001127602-20-027101
2020-10-07 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 262,500, disposed Open Form 4 filing 0001127602-20-026750
2020-06-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 75,525, disposed Open Form 4 filing 0001127602-20-019733
2020-05-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 75,000, disposed Open Form 4 filing 0001127602-20-017178
2020-04-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 75,000, disposed Open Form 4 filing 0001127602-20-014098
2020-03-25 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 75,000, disposed Open Form 4 filing 0001127602-20-011988
2020-02-14 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 105,875, disposed Open Form 4 filing 0001127602-20-006429
2020-01-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 103,675, disposed Open Form 4 filing 0001127602-20-001921

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 44
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Machiels Alec, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001496687

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.